Moleculin Biotech, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price
Moleculin Biotech, Inc. (MBRX) had Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price of $68.57 per share as of 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue · last filed 2026-03-18
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $68.57.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $375.75; Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price as first filed $15.03.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $43.35.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price $66.60; Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price as first filed $4.44.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price | Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price as first filed |
|---|---|---|
| 2025-12-31 | $68.57 10-K · filed 2026-03-18 | |
| 2024-12-31 | $375.75 10-K · filed 2026-03-18 | $15.03 10-K · filed 2025-03-21 |
| 2023-12-31 | $43.35 10-K · filed 2025-03-21 | |
| 2022-12-31 | $66.60 10-K · filed 2024-03-22 | $4.44 10-K · filed 2023-03-22 |
| 2021-12-31 | $6.35 10-K · filed 2023-03-22 | |
| 2020-12-31 | $8.19 10-K · filed 2022-03-24 | |
| 2020-09-30 | $1.37 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $1.58 10-Q · filed 2020-08-12 | |
| 2019-12-31 | $9.53 10-K · filed 2021-03-24 | $1.59 10-K · filed 2020-03-19 |
| 2019-09-30 | $1.60 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $1.80 10-Q · filed 2019-08-16 | |
| 2019-03-31 | $1.81 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $1.78 10-K · filed 2020-03-19 | $1.82 10-K · filed 2019-02-21 |
| 2018-09-30 | $1.80 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $1.80 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $1.81 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $1.93 10-K · filed 2019-02-21 | |
| 2017-09-30 | $2.12 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $3.33 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $3.33 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $3.40 10-K · filed 2018-03-28 | |
| 2015-12-31 | $0.14 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |